BIIB Biogen Inc
18,548
$218.33
$3.09
(1.40%)
| Watchers | 18,548 |
| 52-Wk Low | $189.44 |
| 52-Wk High | $319.76 |
| Market Cap | $32.24B |
| Volume | 615,462.00 |
| 52-Wk High | $319.76 |
| 52-Wk Low | $189.44 |
The Analyst Landscape: 27 Takes On BiogenBenzinga • 8 days ago
Latest Ratings for BIIB
DateFirmActionFromTo Mar 2022StifelDowngradesBuyHold Mar 2022RBC CapitalUpgradesSector PerformOutperform Feb 2022Canaccord GenuityMaintainsBuy
View More Analyst Ratings...
Share to Feed
A new report from Morgan Stanley finds that people using GLP-1 drugs among them Ozempic, Wegovy, Mounjaro, and Zepbound reduce their consumption of tobacco and alcohol while taking the...
Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore
Hot on the heels of last week's tech and momentum rout, shaken traders will have to wait until Friday for the main...
Latest Ratings for BIIB
DateFirmActionFromTo Mar 2022StifelDowngradesBuyHold Mar 2022RBC CapitalUpgradesSector PerformOutperform Feb 2022Canaccord GenuityMaintainsBuy
View More Analyst Ratings...
A closer look at one of the leaders in the global multiple sclerosis therapeutics marketRelated Stocks: BIIB, AZN, PFE, ABBV, MRK, XBI, IBB, SPY, LLY...
Tritonpoint Wealth LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC...
Bankruptcy filings in the healthcare sector rose significantly over the last three years, rising from 25 in 2021 to 46 in 2022 and 79 in 2023, which was the highest level in five years, according to...